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This work pertains to the optimization of enterovirus production using MRC5 cultured on microcarriers within a
bioreactor. This enterovirus, like other lytic viruses, has a rapid decay rate within a production batch, such that a
30% loss of potency is observed per day. Therefore, to maximize the yield of infectious product from the
bioreactor, harvest needs to be timed to maximize the amount of viral production while minimizing the decay.
Viral potency assays have slow turnaround times relative to a production batch, making an online process
analytical technology (PAT) critical to maximize titers. In pursuit of an online method for tracking viral titer, three
different PAT-enabled streams were investigated: dissolved oxygen (DO), viable cell volume (VCV), and oxygen
uptake rate (OUR). DO monitoring was the simplest and leverages the ubiquitous DO trends of production,
however it remains scale and gassing strategy dependent. Dual-frequency capacitance measurements were
utilized to calculate VCV and thereby quantify the magnitude and timing of massive cell lysis that was correlated
in time with peak viral potency. OUR, which quantifies the amount of oxygen being consumed per cellular
volume, leverages both capacitance and DO measurements (in addition to oxygen mass balances pertaining to
the gassing strategy) to provide a holistic scale-independent metabolic PAT readout. The sharp increase we
observe in OUR prior to its decline due to cell lysis appears to be related to increased oxygen demand during
viral production—this sharp increase precedes peak viral potency and peak specific productivity in our process.
Data generated by our PAT tools—DO, VCV, OUR— were compared to potency and specific productivity trends
across 22 batches. In this talk, we will discuss the utility and application of the tools, repeatability of our models
across datasets, and the strengths and weaknesses of each model.
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Figure 1 – N=2 representative batches out of 22
total batches considered in this work.
Production/Infection phase of process.
[A] The dissolved oxygen (DO) concentration plotted
against the potency determined using a viral
potency assay. The DO concentration in the tank
rises as the potency increases.
[B] The viable cell volume (VCV) plotted against the
potency. The viable cell volume drops considerably
before the potency increases. [C] The cell specific
oxygen uptake rate (OUR) plotted against potency.
OUR drops just before the potency is at its peak.
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